Research Publications


  1. Simuni, T, Uribe, L, Cho, HR, Caspell-Garcia, C, Coffey, CS, Siderowf, A et al.. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study. Lancet Neurol. 2019; :. doi: 10.1016/S1474-4422(19)30319-9. PubMed PMID:31678032 .
  2. Prakash, N, Caspell-Garcia, C, Coffey, C, Siderowf, A, Tanner, CM, Kieburtz, K et al.. Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI). Parkinsonism Relat. Disord. 2019;62 :201-209. doi: 10.1016/j.parkreldis.2018.12.025. PubMed PMID:30738748 .
  3. Elson, MJ, Stevenson, EA, Feldman, BA, Lim, J, Beck, CA, Beran, DB et al.. Telemedicine for Parkinson's Disease: Limited Engagement Between Local Clinicians and Remote Specialists. Telemed J E Health. 2018;24 (9):722-724. doi: 10.1089/tmj.2017.0210. PubMed PMID:29297769 .
  4. Korn, RE, Wagle Shukla, A, Katz, M, Keenan, HT, Goldenthal, S, Auinger, P et al.. Virtual visits for Parkinson disease: A multicenter noncontrolled cohort. Neurol Clin Pract. 2017;7 (4):283-295. doi: 10.1212/CPJ.0000000000000371. PubMed PMID:28840919 PubMed Central PMC5566796.
  5. Beck, CA, Beran, DB, Biglan, KM, Boyd, CM, Dorsey, ER, Schmidt, PN et al.. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017;89 (11):1152-1161. doi: 10.1212/WNL.0000000000004357. PubMed PMID:28814455 PubMed Central PMC5595275.
  6. Mammen, JR, Elson, MJ, Java, JJ, Beck, CA, Beran, DB, Biglan, KM et al.. Patient and Physician Perceptions of Virtual Visits for Parkinson's Disease: A Qualitative Study. Telemed J E Health. 2018;24 (4):255-267. doi: 10.1089/tmj.2017.0119. PubMed PMID:28787250 .
  7. Dorsey, ER, Vlaanderen, FP, Engelen, LJ, Kieburtz, K, Zhu, W, Biglan, KM et al.. Moving Parkinson care to the home. Mov. Disord. 2016;31 (9):1258-62. doi: 10.1002/mds.26744. PubMed PMID:27501323 PubMed Central PMC5014631.
  8. Andrzejewski, KL, Dowling, AV, Stamler, D, Felong, TJ, Harris, DA, Wong, C et al.. Wearable Sensors in Huntington Disease: A Pilot Study. J Huntingtons Dis. 2016;5 (2):199-206. doi: 10.3233/JHD-160197. PubMed PMID:27341134 .
  9. Dorsey, ER, Achey, MA, Beck, CA, Beran, DB, Biglan, KM, Boyd, CM et al.. National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers. Telemed J E Health. 2016;22 (7):590-8. doi: 10.1089/tmj.2015.0191. PubMed PMID:26886406 PubMed Central PMC4939367.
  10. Schneider, R, Dorsey, ER, Biglan, K. Telemedicine Care for Nursing Home Residents with Parkinsonism. J Am Geriatr Soc. 2016;64 (1):218-20. doi: 10.1111/jgs.13909. PubMed PMID:26782884 .
  11. Achey, MA, Beck, CA, Beran, DB, Boyd, CM, Schmidt, PN, Willis, AW et al.. Erratum To: Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial. Trials. 2016;17 :7. doi: 10.1186/s13063-015-0984-7. PubMed PMID:26733455 PubMed Central PMC4700612.
  12. Dorsey, ER, Wagner, JD, Bull, MT, Rizzieri, A, Grischkan, J, Achey, MA et al.. Feasibility of Virtual Research Visits in Fox Trial Finder. J Parkinsons Dis. 2015;5 (3):505-15. doi: 10.3233/JPD-150549. PubMed PMID:26406130 PubMed Central PMC4923707.
  13. Arora, S, Venkataraman, V, Zhan, A, Donohue, S, Biglan, KM, Dorsey, ER et al.. Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study. Parkinsonism Relat. Disord. 2015;21 (6):650-3. doi: 10.1016/j.parkreldis.2015.02.026. PubMed PMID:25819808 .
  14. Achey, MA, Beck, CA, Beran, DB, Boyd, CM, Schmidt, PN, Willis, AW et al.. Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial. Trials. 2014;15 :465. doi: 10.1186/1745-6215-15-465. PubMed PMID:25431346 PubMed Central PMC4289172.
  15. Abdolahi, A, Bull, MT, Darwin, KC, Venkataraman, V, Grana, MJ, Dorsey, ER et al.. A feasibility study of conducting the Montreal Cognitive Assessment remotely in individuals with movement disorders. Health Informatics J. 2016;22 (2):304-11. doi: 10.1177/1460458214556373. PubMed PMID:25391849 .
  16. Bull, MT, Darwin, K, Venkataraman, V, Wagner, J, Beck, CA, Dorsey, ER et al.. A pilot study of virtual visits in Huntington disease. J Huntingtons Dis. 2014;3 (2):189-95. doi: 10.3233/JHD-140102. PubMed PMID:25062861 .
  17. Achey, M, Aldred, JL, Aljehani, N, Bloem, BR, Biglan, KM, Chan, P et al.. The past, present, and future of telemedicine for Parkinson's disease. Mov. Disord. 2014;29 (7):871-83. doi: 10.1002/mds.25903. PubMed PMID:24838316 .
  18. Venkataraman, V, Donohue, SJ, Biglan, KM, Wicks, P, Dorsey, ER. Virtual visits for Parkinson disease: A case series. Neurol Clin Pract. 2014;4 (2):146-152. doi: 10.1212/01.CPJ.0000437937.63347.5a. PubMed PMID:24790799 PubMed Central PMC4001180.
  19. Dorsey, ER, Beck, CA, Darwin, K, Nichols, P, Brocht, AF, Biglan, KM et al.. Natural history of Huntington disease. JAMA Neurol. 2013;70 (12):1520-30. doi: 10.1001/jamaneurol.2013.4408. PubMed PMID:24126537 .
  20. George, BP, Scoglio, NJ, Reminick, JI, Rajan, B, Beck, CA, Seidmann, A et al.. Telemedicine in Leading US Neurology Departments. Neurohospitalist. 2012;2 (4):123-8. doi: 10.1177/1941874412450716. PubMed PMID:23983876 PubMed Central PMC3726111.
  21. Dorsey, ER, Venkataraman, V, Grana, MJ, Bull, MT, George, BP, Boyd, CM et al.. Randomized controlled clinical trial of "virtual house calls" for Parkinson disease. JAMA Neurol. 2013;70 (5):565-70. doi: 10.1001/jamaneurol.2013.123. PubMed PMID:23479138 PubMed Central PMC3791511.
  22. Dorsey, ER, Brocht, AF, Nichols, PE, Darwin, KC, Anderson, KE, Beck, CA et al.. Depressed mood and suicidality in individuals exposed to tetrabenazine in a large Huntington disease observational study. J Huntingtons Dis. 2013;2 (4):509-15. doi: 10.3233/JHD-130071. PubMed PMID:25062735 .
  23. HORIZON Investigators of the Huntington Study Group and European Huntington's Disease Network. A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease. JAMA Neurol. 2013;70 (1):25-33. doi: 10.1001/2013.jamaneurol.382. PubMed PMID:23108692 .
  24. Abdolahi, A, Scoglio, N, Killoran, A, Dorsey, ER, Biglan, KM. Potential reliability and validity of a modified version of the Unified Parkinson's Disease Rating Scale that could be administered remotely. Parkinsonism Relat. Disord. 2013;19 (2):218-21. doi: 10.1016/j.parkreldis.2012.10.008. PubMed PMID:23102808 PubMed Central PMC3666325.
  25. Grana, MJ, Bull, MT, Venkataraman, V, Dorsey, ER, Biglan, KM. Web-based clinical assessments for Parkinson's disease: reliable and feasible. Mov. Disord. 2012;27 (11):1466. doi: 10.1002/mds.25121. PubMed PMID:22991090 .
  26. Shprecher, D, Noyes, K, Biglan, K, Wang, D, Dorsey, ER, Kurlan, R et al.. Willingness of Parkinson's disease patients to participate in research using internet-based technology. Telemed J E Health. 2012;18 (9):684-7. doi: 10.1089/tmj.2011.0276. PubMed PMID:22954069 PubMed Central PMC3491628.
  27. Lee, JM, Ramos, EM, Lee, JH, Gillis, T, Mysore, JS, Hayden, MR et al.. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 2012;78 (10):690-5. doi: 10.1212/WNL.0b013e318249f683. PubMed PMID:22323755 PubMed Central PMC3306163.
  28. Biglan, KM, Dorsey, ER, Evans, RV, Ross, CA, Hersch, S, Shoulson, I et al.. Plasma 8-hydroxy-2'-deoxyguanosine Levels in Huntington Disease and Healthy Controls Treated with Coenzyme Q10. J Huntingtons Dis. 2012;1 (1):65-9. doi: 10.3233/JHD-2012-120007. PubMed PMID:25063191 PubMed Central PMC4115297.
  29. Dorsey, R, Biglan, K, Eberly, S, Auinger, P, Brocht, A, Umeh, CC et al.. Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study. PLoS Curr. 2011;3 :RRN1283. doi: 10.1371/currents.RRN1283. PubMed PMID:22139861 PubMed Central PMC3216756.
  30. Dorsey, ER, Deuel, LM, Beck, CA, Gardiner, IF, Scoglio, NJ, Scott, JC et al.. Group patient visits for Parkinson disease: a randomized feasibility trial. Neurology. 2011;76 (18):1542-7. doi: 10.1212/WNL.0b013e3182194bad. PubMed PMID:21525426 PubMed Central PMC3100128.
  31. Dorsey, ER, Voss, TS, Shprecher, DR, Deuel, LM, Beck, CA, Gardiner, IF et al.. A U.S. survey of patients with Parkinson's disease: satisfaction with medical care and support groups. Mov. Disord. 2010;25 (13):2128-35. doi: 10.1002/mds.23160. PubMed PMID:20824736 .
  32. Dorsey, ER, Deuel, LM, Voss, TS, Finnigan, K, George, BP, Eason, S et al.. Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease. Mov. Disord. 2010;25 (11):1652-9. doi: 10.1002/mds.23145. PubMed PMID:20533449 .
  33. Biglan, KM, Voss, TS, Deuel, LM, Miller, D, Eason, S, Fagnano, M et al.. Telemedicine for the care of nursing home residents with Parkinson's disease. Mov. Disord. 2009;24 (7):1073-6. doi: 10.1002/mds.22498. PubMed PMID:19353687 .
  34. Dorsey, ER, Constantinescu, R, Thompson, JP, Biglan, KM, Holloway, RG, Kieburtz, K et al.. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68 (5):384-6. doi: 10.1212/01.wnl.0000247740.47667.03. PubMed PMID:17082464 .
Search PubMed

Get Started

Contact Us


844-77-PDCNY (844-777-3269)